Endocrinology, Vol 120, 1250-1257, Copyright © 1987 by Endocrine Society

ARTICLES

Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro

JM Snyder and CR Mendelson

In the present study, we characterized the proteins associated with a purified lamellar body fraction isolated from human fetal lung explants. We then raised antibodies directed against the major human surfactant apoprotein, a 35-K glycoprotein, and used the technique of immunoblot analysis to evaluate the content of the surfactant apoprotein in human fetal lung explants maintained in serum-free medium in vitro. We found that the 35K surfactant apoprotein was undetectable in homogenates of fetal lung tissue before culture; the surfactant apoprotein was induced in the cultured explants coincident with the appearance of differentiated type II cells. Insulin, at concentrations as low as 2.5 ng/ml, caused marked inhibition of the accumulation of the 35K protein in the cultured fetal lung tissue. The inhibitory effect of insulin was dose dependent and was apparent as early as day 2 of incubation. When explants were cultured in medium containing insulin plus cortisol, the amount of immunoreactive surfactant apoprotein was reduced compared to that of explants cultured in control medium or explants cultured with cortisol alone. On the other hand, as reported previously, insulin and cortisol, in combination, stimulated phosphatidylcholine synthesis. These findings are indicative that the phospholipid and apoprotein components of surfactant are regulated independently. The results of our studies suggest that fetal hyperinsulinemia may cause the production of a surfactant deficient in the 35K apoprotein, and this may provide an explanation for the increased incidence of respiratory distress syndrome in infants of diabetic mothers.

This article has been cited by other articles:

				G. Wang, X. Guo, and J. Floros Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L738 - L748. [Abstract] [Full Text] [PDF]

				J. M. Klein, T. A. McCarthy, J. M. Dagle, and J. M. Snyder Pre- and Postnatal Lung Development, Maturation, and Plasticity: Antisense inhibition of surfactant protein A decreases tubular myelin formation in human fetal lung in vitro Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L386 - L393. [Abstract] [Full Text] [PDF]

				K. R. KHUBCHANDANI and J. M. SNYDER Surfactant protein A (SP-A): the alveolus and beyond FASEB J, January 1, 2001; 15(1): 59 - 69. [Abstract] [Full Text] [PDF]

				J. M. Klein, T. A. McCarthy, J. M. Dagle, and J. M. Snyder Antisense Inhibition of Epidermal Growth Factor Receptor Decreases Expression of Human Surfactant Protein A Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 676 - 684. [Abstract] [Full Text]

				N. V. Patel, M. J. Acarregui, J. M. Snyder, J. M. Klein, M. X. Sliwkowski, and J. A. Kern Neuregulin-1 and Human Epidermal Growth Factor Receptors 2 and 3 Play a Role in Human Lung Development In Vitro Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 432 - 440. [Abstract] [Full Text]

				J. M. Klein, L. J. Dewild, and T. A. McCarthy Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L542 - L551. [Abstract] [Full Text] [PDF]

				D. R. Breed, L. R. Margraf, J. L. Alcorn, and C. R. Mendelson Transcription Factor C/EBP{delta} in Fetal Lung: Developmental Regulation and Effects of Cyclic Adenosine 3',5'-Monophosphate and Glucocorticoids Endocrinology, December 1, 1997; 138(12): 5527 - 5534. [Abstract] [Full Text] [PDF]